Real-world baseline treatment patterns and overall survival (rwOS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States.

被引:0
|
作者
Kariburyo-Yay, Furaha
George, Daniel J.
Aggarwal, Himani
Tepsick, Jon G.
Yu, Rebekah
Li, Weiyan
Orji, Chinelo
Lal, Lincy S.
Ghate, Sameer R.
机构
[1] ConcertAI LLC, Cambridge, MA USA
[2] Duke Univ, Inst Canc, Durham, NC USA
[3] Merck & Co Inc, Rahway, NJ USA
[4] AstraZeneca, Gaithersburg, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5054
引用
收藏
页数:1
相关论文
共 50 条
  • [1] REAL-WORLD TREATMENT AND CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER TREATED WITH OLAPARIB IN THE UNITED STATES
    Daniel, J. George
    Furaha, Kariburyo-Yay
    Himani, Aggarwal
    Jon, Tepsick
    Rebekah, Yu
    Weiyan, Li
    Chinelo, Orji
    Sameer, R. Ghate
    Neeraj, Agarwal
    Michael, T. Schweizer
    Elena, Castro
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [2] Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US
    Shore, N.
    Laliberte, F.
    Ionescu-Ittu, R.
    Gayle, A.
    Amin, S.
    Yang, L.
    Payne, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S534 - S535
  • [3] Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Shore, N.
    Ionescu-Ittu, R.
    Yang, L.
    Laliberte, F.
    Payne, S.
    Gayle, A.
    Amin, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S526 - S527
  • [4] Real-world homologous recombination repair mutation (HRRm) testing patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States
    George, Daniel J.
    Kariburyo-Yay, Furaha
    Aggarwal, Himani
    Tepsick, Jon G.
    Yu, Rebekah
    Li, Weiyan
    McLaurin, Kimmie K.
    Orji, Chinelo
    Lal, Lincy S.
    Ghate, Sameer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 332 - 332
  • [5] Real-world evidence of treatment patterns and pharmacy costs among patients with metastatic castration-resistant prostate cancer (mCRPC) in a managed care population in the United States.
    Moses, Kelvin A.
    Wallace, Katrine
    Landsteiner, Adrienne
    Bunner, Scott
    Engel-Nitz, Nicole
    Lal, Lincy S.
    Golsorkhi, Anthony A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer
    Gupta, Shilpa
    To, Tu My
    Graf, Ryon
    Kadel, Edward E.
    Reilly, Norelle
    Albarmawi, Husam
    JCO PRECISION ONCOLOGY, 2024, 8
  • [7] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 327 - 333
  • [8] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Stephen J. Freedland
    Matthew Davis
    Andrew J. Epstein
    Bhakti Arondekar
    Jasmina I. Ivanova
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 327 - 333
  • [9] Plasma circulating tumor DNA (ctDNA) fraction and real-world overall survival (rwOS) in metastatic castration resistant prostate cancer (mCRPC).
    Stover, Daniel G.
    Morgan, Todd Matthew
    Graf, Ryon
    Li, Gerald
    Castellanos, Emily
    Snow, Tamara
    Swaminathan, Akshay
    Madison, Russell
    Schrock, Alexa Betzig
    Huang, Richard S. P.
    Oxnard, Geoffrey R.
    Venstrom, Jeffrey Michael
    Reichert, Zachery R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US.
    Malangone-Monaco, Elisabetta
    Li, Weiyan
    Noxon, Virginia
    Jiang, Shan
    Amin, Suvina
    Ghate, Sameer
    Swami, Umang
    Agarwali, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)